HAL (France)
open access
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation
Limb-girdle muscular dystrophy R2 (LGMD R2) is an autosomal recessive disorder caused by dysferlin deficiency, leading to progressive muscle weakness and wasting. The lack of reliable clinical biomarkers has limited disease monitoring and therapeutic evaluation. Here, we identified Disabled-2 (DAB2)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Limb Girdle Muscular Dystrophy Type 2E Recruitment Study#897779
- Additional file 1 of Sex differences in MASLD-related atherosclerosis: plaque phenotype, vascular dysfunction, and cardiovascular outcomes#1145950
- High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes#902355
- Dapagliflozin DPPIV Inhibitor add-on Study#226172
- The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy#1321374
Record · ID 1251022
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive